Struggling 23andMe Is Exploring Splitting the DNA Company In Two
23andMe’s stock has been trading below $1 since December, hurt by revelations that hackers were able to access the personal information of around 50% of its subscribers. The company is also facing mounting litigation over the incident. The company is expected to release its Q4 earnings report after market close on Wednesday.
Read more of this story at Slashdot.